The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predicting pathologic complete response (pCR) from clinicopathologic variables and HER2DX genomic test in stage II/III HER2+ breast cancer treated with taxane, trastuzumab, and pertuzumab (THP): Secondary results from the EA1181/CompassHER2 pCR trial.
 
Nadine Tung
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline
Research Funding - AstraZeneca (Inst)
 
Fengmin Zhao
Employment - Novo Nordisk (I)
 
Angela DeMichele
Consulting or Advisory Role - Pfizer (I)
Research Funding - Genentech (Inst); Inivata/NeoGenomics (Inst); Novartis (Inst); Pfizer (Inst)
 
Aleix Prat
Employment - Reveal Genomics
Leadership - Reveal Genomics
Stock and Other Ownership Interests - Reveal Genomics
Honoraria - AstraZeneca; Daiichi Sankyo; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Novartis; Oncolytics; Pfizer; Roche
Research Funding - AstraZeneca; Daiichi Sankyo; Novartis (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - HER2DX filing; METHODS FOR BREAST CANCER TREATMENT AND PREDICTION OF THERAPEUTIC RESPONSE (US 63/023785); PCT/EP2016/080056: HER2 AS A PREDICTOR OF RESPONSE TO DUAL HER2 BLOCKADE IN THE ABSENCE OF CYTOTOXIC THERAPY; TNBC-DX
Travel, Accommodations, Expenses - Daiichi Sankyo
Other Relationship - Oncolytics; Peptomyc
 
Eric Winer
No Relationships to Disclose
 
Jean Wright
Employment - Johns Hopkins Hospital; University of North Carolina at Chapel Hill
Honoraria - American Society for Radiation Oncology; Physicans' Education Resource
Research Funding - Oncospace; Prostate Cancer Foundation-Pfizer Health Equity Challenge (Inst); Prostate Cancer Foundation-Pfizer Health Equity Challenge (Inst)
Patents, Royalties, Other Intellectual Property - Spouse receives royalties from Up To Date (I)
Expert Testimony - Wicker Smith
(OPTIONAL) Uncompensated Relationships - American Society for Radiation Oncology; International Journal of Radiation Oncology Biology Physics
 
Abram Recht
Stock and Other Ownership Interests - Imagine Scientific
Consulting or Advisory Role - CareCore
(OPTIONAL) Uncompensated Relationships - Imagine Scientific
 
Anna Weiss
Consulting or Advisory Role - Merck; Myriad Genetics; Myriad Genetics
Research Funding - Myriad Genetics (Inst)
 
Judy Tjoe
No Relationships to Disclose
 
Sheldon Feldman
Consulting or Advisory Role - IceCure; Stryker/Novadaq
 
Gabrielle Rocque
Employment - Atlas Oncology Partners
Consulting or Advisory Role - Armada/Rubicon (Inst); Gilead Sciences; Pfizer
Research Funding - Daiichi Sankyo/Astra Zeneca; Genentech; Gilead Sciences; Pfizer
 
Mary Lou Smith
Consulting or Advisory Role - Bayer (Inst); Novartis; Pfizer
Research Funding - Exact Sciences (Inst); Foundation Medicine (Inst); Genentech (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Seagan (Inst)
 
Ciara O'Sullivan
Honoraria - AstraZeneca (Inst); Medscape (Inst); Sanford Health (Inst); Seagen (Inst); Seagen (Inst)
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; Pfizer; Seagen; Seagen
Research Funding - Academic & Community Cancer Research United (Inst); Bavarian Nordic (Inst); Genentech (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Tesaro (Inst)
 
Sagar Sardesai
Honoraria - AstraZeneca; Gilead Sciences; Stemline Therapeutics
Consulting or Advisory Role - Novartis
Speakers' Bureau - Immunomedics
Travel, Accommodations, Expenses - Novartis
 
Patricia Villagrasa
Employment - REVEAL GENOMICS SL; REVEAL GENOMICS SL; REVEAL GENOMICS SL
Leadership - REVEAL GENOMICS SL; REVEAL GENOMICS SL
Stock and Other Ownership Interests - REVEAL GENOMICS SL
Patents, Royalties, Other Intellectual Property - PCT/EP2022/086493; PCT/EP2023/060810
 
Sunil Badve
Honoraria - AstraZeneca; Bristol Myers Squibb Foundation; Dako/Agilent Technologies; Ventana Medical Systems
Consulting or Advisory Role - Agilent; BMS; Ventana Medical Systems
Speakers' Bureau - Agilent; AstraZeneca; Targos GmbH
Research Funding - Bristol Myers Squibb Foundation (Inst); Caris Life Sciences (Inst); Dako/Agilent Technologies (Inst); Lilly (Inst)
Patents, Royalties, Other Intellectual Property - E-Score for predicting recurrence of DCIS (Inst); EarlyR - signature for ER+ breast cancer (Inst)
 
Ann Partridge
Patents, Royalties, Other Intellectual Property - Wolters Kluwer- royalties for authorship of UpToDate
 
Kathy Miller
Consulting or Advisory Role - Celcuity; Genentech/Roche; Merck
Research Funding - Genentech (Inst); Radionetics (Inst); RayzeBio (Inst)
 
Lisa Carey
Research Funding - AstraZeneca (Inst); Gilead Sciences (Inst); Lilly (Inst); NanoString Technologies (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Veracyte (Inst)
(OPTIONAL) Uncompensated Relationships - Reveal Genomics
 
Antonio Wolff
Patents, Royalties, Other Intellectual Property - Antonio Wolff has been named as inventor on one or more issued patents or pending patent applications relating to methylation in breast cancer, and has assigned his rights to JHU, and participates in a royalty sharing agreement with JHU.